CELEGAGE Trademark

Trademark Overview


On Tuesday, October 17, 2023, a trademark application was filed for CELEGAGE with the United States Patent and Trademark Office. The USPTO has given the CELEGAGE trademark a serial number of 79386468. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 17, 2024. This trademark is owned by Rejuvenate Biomed NV. The CELEGAGE trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Laboratory apparatus and instruments for inputting, extracting, transmitting, processing and storing data, in particular scientific and medical data, namely, laboratory robots, data processors, electronic data loggers; scientific research and laboratory apparatus, namely, bio-chips for research or scientific purposes, pharmaceutical and scientific research equipment for use in mass spectrometers, electrodes for laboratory research; educational apparatus and simulators, namely, downloadable educational software featuring instruction in electronic clinicians training simulators; incubators for laboratory use; bioreactors for laboratory use; models for scientific experiments in laboratories, namely, downloadable computer simulation software for modeling the impact of drug combinations on health span markers; DNA chips; downloadable artificial intelligence software for data analysis and database management for use in the life sciences research field, pharmaceutical research, medical resear...

Pharmaceutical services, namely, pharmaceutical compounding, pharmaceutical advice; pharmaceutical consultation; pharmaceutical advisory services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services; medical consultancy services; medical advisory services; medical evaluation services, namely, medical testing for fitness evaluation, medical evaluation of cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and conditions, conducting medical physical evaluations; medical diagnostic services; medical examination services; services for the provision of medical care information, namely, providing medical care information, providing medical care information ...

Pharmaceutical research services; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research of pharmaceuticals; testing of pharmaceuticals; research relating to pharmaceuticals; pharmaceutical products development; development of gene-based medicines; drug discovery services; conducting clinical trials for others for pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment, namely, conducting scientific feasibility studies; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals, pharmaceutical research and development; toxicity testing for scientific research purposes; toxicity analysis for scientific research purposes; information technology services for the pharmaceutical and healthcare industries, namely, information technology consultancy relating to instal...
celegage

General Information


Serial Number79386468
Word MarkCELEGAGE
Filing DateTuesday, October 17, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements


Goods and ServicesLaboratory apparatus and instruments for inputting, extracting, transmitting, processing and storing data, in particular scientific and medical data, namely, laboratory robots, data processors, electronic data loggers; scientific research and laboratory apparatus, namely, bio-chips for research or scientific purposes, pharmaceutical and scientific research equipment for use in mass spectrometers, electrodes for laboratory research; educational apparatus and simulators, namely, downloadable educational software featuring instruction in electronic clinicians training simulators; incubators for laboratory use; bioreactors for laboratory use; models for scientific experiments in laboratories, namely, downloadable computer simulation software for modeling the impact of drug combinations on health span markers; DNA chips; downloadable artificial intelligence software for data analysis and database management for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; downloadable artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; downloadable artificial intelligence software for data analysis; downloadable software using artificial intelligence for machine learning for healthcare; downloadable health monitoring software for collecting, storing, computing, and analyzing health data; downloadable software relating to the medical field for controlling and managing patient medical information; downloadable software relating to the pharmaceutical field for drug discovery and development for data analysis; downloadable bioinformatics software for drug discovery and development, for controlling and managing patient medical information; electronic databases, namely, downloadable databases and electronic database recorded on computer media, for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data
Goods and ServicesPharmaceutical services, namely, pharmaceutical compounding, pharmaceutical advice; pharmaceutical consultation; pharmaceutical advisory services; provision of pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services; medical consultancy services; medical advisory services; medical evaluation services, namely, medical testing for fitness evaluation, medical evaluation of cancer, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and conditions, conducting medical physical evaluations; medical diagnostic services; medical examination services; services for the provision of medical care information, namely, providing medical care information, providing medical care information via a website; medical services for the diagnosis of conditions of the human body; medical services for the treatment of conditions of the human body; performing diagnosis of diseases; medical care and analysis services relating to patient treatment; medical screening; drug screening for medical purposes; medical and health services relating to dna, genetics and genetic testing, namely, medical services, medical consultations, health care; genetic testing for medical purposes; medical tests, namely, medical testing services; provision of medical information in the field of prevention, screening, diagnosis and treatment of patients
Goods and ServicesPharmaceutical research services; pharmaceutical product evaluation; research and development in the field of microorganisms and cells; research of pharmaceuticals; testing of pharmaceuticals; research relating to pharmaceuticals; pharmaceutical products development; development of gene-based medicines; drug discovery services; conducting clinical trials for others for pharmaceutical products; scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific risk assessment, namely, conducting scientific feasibility studies; consultancy in the field of pharmaceutical research; services for assessing the efficiency of pharmaceuticals, namely, testing of pharmaceuticals, pharmaceutical research and development; toxicity testing for scientific research purposes; toxicity analysis for scientific research purposes; information technology services for the pharmaceutical and healthcare industries, namely, information technology consultancy relating to installation, maintenance and repair of computer software; conducting early evaluations in the field of new pharmaceuticals, namely, testing of pharmaceuticals; providing information about pharmaceutical research, namely, the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals; chemical research and analysis services; medical and pharmacological research services; scientific services and research relating thereto, namely, scientific research, scientific laboratory services, scientific research consulting; scientific research for medical purposes; scientific research for medical purposes in the area of diseases; medical and scientific research, namely, conducting clinical trials for others; genetic research, namely, providing scientific research information in the field of genetics, providing medical research information in the field of genetics; genetic mapping for scientific purposes; dna screening for scientific research purposes; providing scientific information in the field of medical disorders and their treatment; Providing temporary use of non- downloadable artificial intelligence computer programs on data networks for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; platforms for artificial intelligence as software as a service (SaaS), namely, platform as a service (PAAS) featuring computer software platforms using artificial intelligence for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring computer software platforms using artificial intelligence for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for data analysis for use in the life sciences research field, pharmaceutical research, medical research, and drug discovery and development; software as a service (SaaS) services featuring artificial intelligence software for healthcare for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SaaS) services featuring artificial intelligence software for data analysis; software as a service (SaaS) services featuring software using artificial intelligence for machine learning for healthcare; software as a service (SaaS) services featuring health monitoring software for collecting, storing, computing, and analyzing health data; software as a service (SaaS) services featuring software relating to the medical field for controlling and managing patient medical information; software as a service (SaaS) services featuring bioinformatics software for drug discovery and development, for controlling and managing patient medical information; providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; computer programming in the medical field; scientific computer programming services; artificial intelligence technology consultancy; research in the field of artificial intelligence

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, December 29, 2023
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 29, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRejuvenate Biomed NV
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE

Party NameRejuvenate Biomed NV
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events


Event DateEvent Description
Thursday, December 28, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, March 27, 2024ASSIGNED TO EXAMINER
Friday, March 29, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 2, 2024APPLICATION FILING RECEIPT MAILED
Thursday, March 28, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 16, 2024REFUSAL PROCESSED BY MPU
Wednesday, May 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 29, 2024FINAL REFUSAL WRITTEN
Wednesday, April 17, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 9, 2024REFUSAL PROCESSED BY IB
Wednesday, May 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 29, 2024FINAL REFUSAL E-MAILED
Saturday, June 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 13, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 13, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, August 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 13, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, August 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED